Skip to main content

Mesenchymal Stem Cell Therapy for Liver Cirrhosis Treatment: Mechanisms and Bioeffects

  • Chapter
  • First Online:
Book cover Liver, Lung and Heart Regeneration

Part of the book series: Stem Cells in Clinical Applications ((SCCA))

  • 829 Accesses

Abstract

Liver cirrhosis is characterized by inflammation and necrosis induced by Kupffer cells and the activation of hepatic satellite cells. In recent years, stem cell therapy has become a promising therapy for treatment. Some in vitro studies and in vivo preclinical trials have demonstrated that mesenchymal stem cells (MSCs) may improve liver cirrhosis by different mechanisms. Differentiation potential and immune modulation of MSCs are important considerations of MSC transplantation and can affect liver function improvement after transplantation. This chapter will summarize and discuss the latest MSC transplantations for liver cirrhosis treatment and some mechanisms by which MSCs exert their bioeffects on the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abbas Sahebghadam L (2012) High yield generation of hepatocyte like cells from adipose derived stem cells. Sci Res Essays 7:1141–1147

    Google Scholar 

  • Abbasoglu O, Levy MF, Brkic BB, Testa G, Jeyarajah DR, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB (1997) Ten years of liver transplantation: an evolving understanding of late graft Loss1. Transplantation 64:1801–1807

    Article  CAS  PubMed  Google Scholar 

  • Acquistapace A, Bru T, Lesault PF, Figeac F, Coudert AE, le Coz O, Christov C, Baudin X, Auber F, Yiou R, Dubois-Randé JL, Rodriguez AM (2011) Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells 29:812–824

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815–1822

    Google Scholar 

  • Ai C (1991) Mesenchymal stem cells. J Orthop Res 9:641–650

    Article  Google Scholar 

  • Alison MR, Islam S, Lim S (2009) Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 217:282–298

    Article  CAS  PubMed  Google Scholar 

  • Anjos-Afonso F, Bonnet D (2007) Non-hematopoietic/endothelial SSEA-1pos cells defines the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 109:1298–1306

    Google Scholar 

  • Anna CP, Campanale M, Gasbarrini A, Gasbarrini G (2010) Stem cell-based therapies for liver diseases: state of the art and new perspectives. Stem Cells Int 2010:10

    Google Scholar 

  • Antonino S, Carmen G-G, Philippe M, Baertschiger RM, Niclauss N, Mentha G, Majno P, Serre-Beinier V, Buhler L (2011) Interleukin-1 receptor antagonist modulates the early phase of liver regeneration after partial hepatectomy in mice. PloS One 6:e25442

    Google Scholar 

  • Antonio U, Lorenzo M, Vito P (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726–736

    Article  Google Scholar 

  • Aquino JB, Bolontrade MF, Garcia MG, Podhajcer OL, Mazzolini G (2010) Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma. Gene Ther 17:692–708

    Article  CAS  PubMed  Google Scholar 

  • Bagher L, Ensieh NE, Peyvand A (2012) Stem cell therapy in treatment of different diseases. Acta Med Iran 50:79–96

    Google Scholar 

  • Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G, Okochi H, Ochiya T (2007) Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46:219–228

    Article  CAS  PubMed  Google Scholar 

  • Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kawamata M, Kato T, Okochi H, Ochiya T (2008) IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 26:2705–2712

    Article  CAS  PubMed  Google Scholar 

  • Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42–48

    Google Scholar 

  • Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, Galun E, Rachmilewitz J (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214–2219

    Google Scholar 

  • Botha J, Spearman C, Millar A, Michell L, Gordon P, Lopez T, Butt A, Thomas J, McCulloch M, James M (2000) Ten years of liver transplantation at Groote Schuur Hospital. SAMJ 90:880–883

    CAS  PubMed  Google Scholar 

  • Briquet A, Gregoire C, Comblain F, Servais L, Zeddou M, Lechanteur C, Beguin Y (2014) Human bone marrow, umbilical cord or liver mesenchymal stromal cells fail to improve liver function in a model of CCl4-induced liver damage in NOD/SCID/IL-2Rgamma(null) mice. Cytotherapy 16:1511–1518

    Article  CAS  PubMed  Google Scholar 

  • Busuttil RW, Shaked A, Millis JM, Jurim O, Colquhoun SD, Shackleton CR, Nuesse BJ, Csete M, Goldstein LI, McDiarmid SV (1994) One thousand liver transplants. The lessons learned. Ann Surg 219:490

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen X, Gan Y, Li W, Su J, Zhang Y, Huang Y, Roberts AI, Han Y, Li J, Wang Y, Shi Y (2014) The interaction between mesenchymal stem cells and steroids during inflammation. Cell Death Dis 5:e1009

    Google Scholar 

  • Dacosta RF, Lee C, Walker S, Lehec S, Fitzpatrick E, Dhawan A, Filippi C (2015) Investigation of the mitochondrial transfer from human mesenchymal stem/stromal cells to human primary hepatocytes through tunnelling nanotubes as a potential mechanism for cell survival and function enhancement during hepatocyte transplantation. Xenotransplantation 22(S1):S47

    Google Scholar 

  • Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875–884

    Google Scholar 

  • Deeg H (2007) How I treat refractory acute GVHD. Blood 109:4119–4126

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dennis JE, Charbord P (2002) Origin and differentiation of human and murine stroma. Stem Cells 20:205–214

    Google Scholar 

  • di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E (2008) Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 57:223–231

    Google Scholar 

  • Di Nicola M, Carlo-stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838–3843

    Article  PubMed  Google Scholar 

  • Eom YW, Shim KY, Baik SK (2015) Mesenchymal stem cell therapy for liver fibrosis. Korean J Intern Med 30:580–589

    Article  PubMed  PubMed Central  Google Scholar 

  • Fitzpatrick E, Wu Y, Dhadda P, Hughes RD, Mitry RR, Qin H, Lehec SC, Heaton ND, Dhawan A (2015) Coculture with mesenchymal stem cells results in improved viability and function of human hepatocytes. Cell Transplant 24:73–83

    Article  PubMed  Google Scholar 

  • Forbes SJ (2009) Stem cell therapy for liver disease. World Stem Cell Report (http://www.worldstemcellsummit.com)

  • Forbes SJ, Newsome PN (2012) New horizons for stem cell therapy in liver disease. J Hepatol 56:496–499

    Article  PubMed  Google Scholar 

  • Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230–247

    Article  CAS  PubMed  Google Scholar 

  • Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655–1669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fung ME, Thebaud B (2014) Stem cell-based therapy for neonatal lung disease: it is in the juice. Pediatr Res 75:2–7

    Article  PubMed  Google Scholar 

  • Gi-Ppeum L, Jeong W-I, Jeong D-H, Do S-H, Kim T-H, Jeong K-S (2005) Diagnostic evaluation of carbon tetrachloride-induced rat hepatic cirrhosis model. Anticancer Res 25:1029–1038

    Google Scholar 

  • Guilherme B, Kretzmann NA, Tieppo J, Filho G.P, Cruz CU, Meurer L, Silveira TRD, Santos JLD, Marroni CUA, Marroni NP et al (2011) Bone marrow cells reduce collagen deposition in the rat model of common bile duct ligation. J Cell Sci Ther 2:112

    Google Scholar 

  • Harn HJ, Lin SZ, Hung SH, Subeq YM, Li YS, Syu WS, Ding DC, Lee RP, Hsieh DK, Lin PC et al (2012) Adipose-derived stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function. Cell Transplant 21:2753–2764

    Article  PubMed  Google Scholar 

  • Hiroyuki K, Yasuhiro F, Takumi T, Junji I, Naoya K, Kouji N, Tsuruyama T, Uemoto S, Kobayashi E (2011) Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PloS one 6(4):e19195

    Google Scholar 

  • Hodgkinson CP et al (2010) Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 21:1513–1526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hong J, Jin H, Han J, Hu H, Liu J, Li L, Huang Y, Wang D, Wu M, Qiu L et al (2014) Infusion of human umbilical cord derived mesenchymal stem cells effectively relieves liver cirrhosis in DEN induced rats. Mol Med Rep 9:1103–1111

    CAS  PubMed  Google Scholar 

  • Horwitz EM, Le Blanc K, Dominici M (2005) Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cytotherapy 7:393–395

    Google Scholar 

  • Huang CK, Lee SO, Lai KP, Ma WL, Lin TH, Tsai MY, Luo J, Chang C (2013) Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis. Hepatology 57:1550–1563

    Google Scholar 

  • In’t Anker PS, Noort WA, Scherjon SA (2003a) Mesenchymal stem cells in human second trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88:845–852

    Google Scholar 

  • In’t Anker PS, Scherjon SA, Kleijburg-van der Keur C (2003b) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102:1548–1549

    Google Scholar 

  • In’t Anker PS, Scherjon SA, Kleijburg-van der Keur C (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22:1338–1345

    Google Scholar 

  • Isoda K, Kojima M, Takeda M, Higashiyama S, Kawase M, Yagi K (2004) Maintenance of hepatocyte functions by coculture with bone marrow stromal cells. J Biosci Bioeng 97:343–346

    Article  CAS  PubMed  Google Scholar 

  • Jang YO, Kim MY, Cho MY, Baik SK, Cho YZ, Kwon SO (2014) Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model. BMC Gastroenterol 14:198. http://www.biomedcentral.com/1471-1230X/1414/1198

  • Jung KH, Shin HP, Lee S, Lim YJ, Hwang SH, Han H, Park HK, Chung JH, Yim SV (2009) Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model. Liver Int 29:898–909

    Article  CAS  PubMed  Google Scholar 

  • Kang L-I, Mars WM, Michalopoulos GK (2012) Signals and cells involved in regulating liver regeneration. Cell 1:1261–1292

    Article  CAS  Google Scholar 

  • Kim TH, Mars WM, Stolz DB, Michalopoulos GK (2000) Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration. Hepatology 31(1):75–82

    Google Scholar 

  • Kim W, Matsumoto K, Bessho K, Nakamura T (2005) Growth Inhibition and apoptosis in liver myofibroblast promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 166:1017–1028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia J, Schwabe RF, Brenner DA (2006) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45:429–438

    Article  CAS  PubMed  Google Scholar 

  • Koellensperger E, Niesen W, Kolbenschlag J, Gramley F, Germann G, Leimer U (2013) Human adipose tissue derived stem cells promote liver regeneration in a rat model of toxic injury. Stem Cells Int 2013:534263

    Article  PubMed  PubMed Central  Google Scholar 

  • Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, Scheideler M, Windhager R, Preisegger K-H, Trajanoski Z (2007) Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 8:1–15

    Article  Google Scholar 

  • Le Blanc K, Ringdén O (2005) Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:321–334

    Article  PubMed  Google Scholar 

  • Le Blanc K, Ringdén O (2007) Immunomodulation by mesenchymal stem cells and clinical experience. J Int Med 262:509–525

    Google Scholar 

  • Li C, Kong Y, Wang H, Wang S, Yu H, Liu X (2009) Homing of bone marrow mesenchymal stem cells mediated by sphingo- sine 1-phosphate contributes to liver fibrosis. J Hepatol 50:1174–1183

    Google Scholar 

  • Li S, Sun Z, Lv G, Guo X, Zhang Y et al (2009) Microencapsulated UCB cells repair hepatic injure by intraperitoneal transplantation. Cytotherapy 11:1032–1040

    Google Scholar 

  • Li H, Lu Y, Witek RP, Chang LJ, Campbell-Thompson M, Jorgensen M, Petersen B, Song S (2010a) Ex vivo transduction and transplantation of bone marrow cells for liver gene delivery of alpha1-antitrypsin. Mol Ther 18:1553–1558

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li J, Tao R, Wu W, Cao H, Xin J, Li J, Guo J, Jiang L, Gao C, Demetriou AA et al (2010b) 3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes. Stem Cells Dev 19:1427–1436

    Article  CAS  PubMed  Google Scholar 

  • Li Z, He C, Xiao J, Chen Z (2013) Treating end-stage liver diseases with mesenchymal stem cells: an oak is not felled at one stroke. OA Tissue Eng 1(1):3

    Google Scholar 

  • Li B, Shao Q, Ji D, Li F, Chen G (2015) Mesenchymal stem cells mitigate cirrhosis through BMP7. Cell Physiol Biochem 35:433–440

    Google Scholar 

  • Lian J, Lu Y, Xu P, Ai A, Zhou G, Liu W, Cao Y, Zhang WJ (2014) Prevention of liver fibrosis by intrasplenic injection of high-density cultured bone marrow cells in a rat chronic liver injury model. PLoS One 9:e103603

    Article  PubMed  PubMed Central  Google Scholar 

  • Liang X, Ding Y, Zhang Y, Tse HF, Lian Q (2014) Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant 23:1045–1059

    Article  PubMed  Google Scholar 

  • Linhua Zheng JC, Yongquan S, Xinmin Z, Ling T, Qiang L, Lina C, Zheyi H, Ying H, Daiming F (2013) Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17. Cell Biosci 3:46

    Google Scholar 

  • Lorenzini S, Andreone P (2007) Stem cell therapy for human liver cirrhosis: a cautious analysis of the results. Stem Cells 25:2383–2384

    Article  PubMed  Google Scholar 

  • Lue J, Lin G, Ning H, Xiong A, Lin CS, Glenn JS (2010) Transdifferentiation of adipose-derived stem cells into hepatocytes: a new approach. Liver Int 30:913–922

    Article  CAS  PubMed  Google Scholar 

  • Mehdi M, Reza M, Siavosh N-M, Sepideh H-A, Nasser R et al (2005) Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis. Dig Dis Sci 50:547–551

    Google Scholar 

  • Meier RP, Mahou R, Morel P, Meyer J, Montanari E, Muller YD, Christofilopoulos P, Wandrey C, Gonelle-Gispert C, Buhler LH (2015) Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice. J Hepatol 62:634–641

    Article  CAS  PubMed  Google Scholar 

  • Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, Baharvand H, Ghavamzadeh A, Malekzadeh R (2007) Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 10:459–466

    CAS  PubMed  Google Scholar 

  • Mohsin S, Shams S, Ali Nasir G, Khan M, Javaid Awan S, Khan SN, Riazuddin S (2011) Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue. Differentiation 81:42–48

    Article  CAS  PubMed  Google Scholar 

  • Moon YJ, Yoon HH, Lee MW, Jang IK, Lee DH, Lee JH, Lee SK, Lee KH, Kim YJ, Eom YW (2009) Multipotent progenitor cells derived from human umbilical cord blood can differentiate into hepatocyte-like cells in a liver injury rat model. Transplant Proc 41:4357–4360

    Google Scholar 

  • Murray Christopher JL, Vos T et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223

    Google Scholar 

  • Nasir GA, Mohsin S, Khan M, Shams S, Ali G, Khan SN, Riazuddin S (2013) Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice. J Transl Med 11:78. http://www.translational-medicine.com/content/11/11/78

  • Nhung HT, Nam HN, Trinh VL, Ngoc BV, Nghia H, Thanh VN, Huy ML, Ngoc KP, Phuc VP (2016). Comparison of the treatment efficiency of bone marrow-derived mesenchymal stem cell transplantation via tail and portal veins in CCl4-induced mouse liver fibrosis. Stem Cells Int 2016:13

    Google Scholar 

  • Nussler A et al (2006) Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 45:144–159

    Article  CAS  PubMed  Google Scholar 

  • Ozaki Y, Nishimura M, Sekiya K, Suehiro F, Kanawa M, Nikawa H (2007) Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev 16:119–129

    Google Scholar 

  • Pan RL, Wang P, Xiang LX, Shao JZ (2011) Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation. J Biol Chem 286:12340–12348

    Google Scholar 

  • Park JA, Kim GD, Cha JH, Kim HL, Choi ES, Jung ES, Yoon SK, Oh SH, Bae SH (2011) Therapeutic potential of human mesenchymal stem cells derived from amnion and bone marrow in a rat model of acute liver injury and fibrosis. Tissue Eng Regen Med 8:422–431

    Google Scholar 

  • Phillips MI, Tang YL (2008) Genetic modification of stem cells for transplantation. Adv Drug Deliv Rev 60:160–172

    Google Scholar 

  • Pinelopi M, Vasiliki A, Emmanuel T, Graziella I, Kate J, Graham S, Amar PD, James OB, David P, Andrew KB (2010) Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity. Liver Transpl 16:64–73

    Article  Google Scholar 

  • Pittenger MF, Mackay AM, Beck SC (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147

    Google Scholar 

  • Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25:1737–1745

    Google Scholar 

  • Pournasr B, Mohamadnejad M, Bagheri M, Aghdami N, Shahsavani M, Malekzadeh R, Baharvand H (2011) In vitro differentiation of human bone marrow mesenchymal stem cells into hepatocyte-like cells. Arch Iran Med 14:244–249

    CAS  PubMed  Google Scholar 

  • Puglisi MA, Saulnier N, Piscaglia AC, Tondi P, Agnes S, Gasbarrini A (2011a) Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives. Eur Rev Med Pharmacol Sci 15:355–364

    CAS  PubMed  Google Scholar 

  • Puglisi MA, Tesori V, Lattanzi W, Piscaglia AC, Gasbarrini GB, D’Ugo DM, Gasbarrini A (2011b) Therapeutic implications of mesenchymal stem cells in liver injury. J Biomed Biotechnol 2011:860578

    Article  PubMed  PubMed Central  Google Scholar 

  • Ren H, Zhao Q, Cheng T, Lu S, Chen Z, Meng L, Zhu X, Yang S, Xing W, Xiao Y et al (2010) No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis. Cytotherapy 12:371–383

    Article  CAS  PubMed  Google Scholar 

  • Ruiz JC (2011) Generation of adipose stromal cell-derived hepatic cells. Methods Mol Biol 702:249–260

    Article  CAS  PubMed  Google Scholar 

  • Saito Y, Shimada M, Utsunomiya T, Ikemoto T, Yamada S, Morine Y, Imura S, Mori H, Arakawa Y, Kanamoto M, Iwahashi S, Takasu C (2014) Homing effect of adipose-derived stem cells to the injured liver: the shift of stromal cell-derived factor 1 expressions. J Hepatobiliary Pancreat Sci. doi:10.1002/jhbp.147

  • Sanchez-Ramos J, Song S, Cardozo-Pelaez F (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164:247–256

    Google Scholar 

  • Sandra AJ, Valerie DR, Catherine MV, Stefaan WVG (2013) Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells. Immunol Cell Biol 91:32–39

    Article  Google Scholar 

  • Schwartz RE, Reyes M, Koodie L (2002) Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109:1291–1302

    Google Scholar 

  • Sgodda M, Aurich H, Kleist S, Aurich I, Konig S, Dollinger MM, Fleig WE, Christ B (2007) Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res 313:2875–2886

    Article  CAS  PubMed  Google Scholar 

  • Shi XL, Mao L, Xu BY, Xie T, Zhu ZH, Chen JH, Li L, Ding YT (2008) Optimization of an effective directed differentiation medium for differentiating mouse bone marrow mesenchymal stem cells into hepatocytes in vitro. Cell Biol Int 32:959–965

    Article  CAS  PubMed  Google Scholar 

  • Silva Jr WA, Covas D, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL (2003) The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 21:661–669

    Google Scholar 

  • Soland MA, Bego MG, Colletti E, Porada CD, Zanjani ED, St Jeor S, Almeida-Porada G. (2012). Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus US proteins. PLoS One 7:e36163

    Google Scholar 

  • Stefan M, Thomas B, Jürgen R, Christoph S, Heiner W (2015) Hepatology, 6th edn. Flying Publisher, Germany

    Google Scholar 

  • Sterodimas A, de Faria J, Nicaretta B, Pitanguy I (2010) Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications. J Plast Reconstr Aesthet Surg 63:1886–1892

    Article  PubMed  Google Scholar 

  • Sudan DL, Shaw BW Jr, Langnas AN (1998) Causes of late mortality in pediatric liver transplant recipients. Ann Surg 227:289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sudeepta A, Mark FP (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815–1822

    Article  Google Scholar 

  • Taléns-Visconti R, Bonora A, Jover R, Mirabet V, Carbonell F, Castell JV, Gómez-Lechón MJ (2006) Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol 12(36):5834–5845

    Google Scholar 

  • Tan CY, Lai RC, Wong W, Dan YY, Lim S-K, Ho HK (2014) Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther 5(3):76

    Article  PubMed  PubMed Central  Google Scholar 

  • Thorgeirsson SS (1996) Hepatic stem cells in liver regeneration. FASEB J 10:1249–1256

    CAS  PubMed  Google Scholar 

  • Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389–397

    Google Scholar 

  • Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 383:1749–1761

    Article  PubMed  Google Scholar 

  • Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M (2014) Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells 32:2818–2823

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Ge S, McNamara G, Hao QL, Crooks GM, Nolta JA (2003) Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood 101:4201–4208

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang M, Pei H, Zhang L, Guan L, Zhang R, Jia Y, Li B, Yue W, Wang Y, Pei X (2010) Hepatogenesis of adipose-derived stem cells on poly-lactide-co-glycolide scaffolds: in vitro and in vivo studies. Tissue Eng 16:1041–1050

    Google Scholar 

  • Wang Y, Lian F, Li J, Fan W, Xu H, Yang X, Liang L, Chen W, Yang J (2012) Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats. J Transl Med 10:133

    Article  PubMed  PubMed Central  Google Scholar 

  • Wilson A, Butler PE, Seifalian AM (2011) Adipose-derived stem cells for clinical applications: a review. Cell Prolif 44:86–98

    Article  CAS  PubMed  Google Scholar 

  • Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, Chen L, Lv S, Li Y, Yu S et al (2012) Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 27(Suppl 2):112–120

    Article  CAS  PubMed  Google Scholar 

  • Zhao Q, Ren H, Zhu D, Han Z (2009) Stem/progenitor cells in liver injury repair and regeneration. Biol Cell 101:557–571

    PubMed  Google Scholar 

  • Zhen Fan Y, Ho DWY, Ngai P, Lau CK, Zhao Y, Poon RTP, Fan ST (2007) Antiinflammatory properties of IL-10 rescue small-for-size liver grafts. Liver Transpl 13:558–565

    Article  Google Scholar 

  • Zheng Z, Wang F-S (2013) Stem cell therapies for liver failures and cirrhosis. J Hepatol 59:183–185

    Article  Google Scholar 

  • Zuk PA, Zhu M, Mizuno H (2001) Multilineage cells from human adipose tissue: implications for cell based therapies. Tissue Eng 7:211–228

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Phuc Van Pham .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Truong, N.H., Van Pham, P. (2017). Mesenchymal Stem Cell Therapy for Liver Cirrhosis Treatment: Mechanisms and Bioeffects. In: Pham, P. (eds) Liver, Lung and Heart Regeneration. Stem Cells in Clinical Applications. Springer, Cham. https://doi.org/10.1007/978-3-319-46693-4_4

Download citation

Publish with us

Policies and ethics